ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations

August 3, 1979

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011